Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation-Reference-Cited by-同舟云学术

Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation

Published:2009-10 Issue:42 Volume:284 Page:28856-28864
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Poirier Steve,Mayer Gaetan,Poupon Viviane,McPherson Peter S.,Desjardins Roxane,Ly Kevin,Asselin Marie-Claude,Day Robert,Duclos Franck J.,Witmer Mark,Parker Rex,Prat Annik,Seidah Nabil G.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. A Receptor-Mediated Pathway for Cholesterol Homeostasis

2. Genetic heterogeneity of autosomal dominant hypercholesterolemia

3. The proprotein convertases are potential targets in the treatment of dyslipidemia

4. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation

Cited by 231 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The singular French PCSK9-p.Ser127Arg gain-of-function variant: a significant player in cholesterol levels from a 775-year-old common ancestor;Atherosclerosis;2024-09

2. Novel drug design and repurposing: An opportunity to improve translational research in cardiovascular diseases?;Archiv der Pharmazie;2024-07-29

3. Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition—Part one: Pleiotropic pro‐atherosclerotic effects of PCSK9;European Journal of Clinical Investigation;2024-06-26

4. A promising therapy for fatty liver disease: PCSK9 inhibitors;Phytomedicine;2024-06

5. Platelets as an inter‐player between hyperlipidaemia and atherosclerosis;Journal of Internal Medicine;2024-05-05